
In light of ongoing discussions over potential U.S. tariffs, a German government spokesperson made it clear on Friday that “nothing is off the table” regarding possible punitive measures. This statement underscores the country’s readiness to consider various options in response to the looming trade tensions with the United States.
The spokesperson was specifically asked whether countermeasures might target U.S. technology companies, to which they responded, “At the moment, nothing is off the table, but instead everything is being looked at.” This suggests that Germany is exploring a broad range of potential actions as the situation unfolds.
According to Reuters, the spokesperson emphasized that any decisions would be made collaboratively within the European Union and under the leadership of the European Commission. “Decisions must be made jointly and in consideration of the costs and benefits within the European Union,” the spokesperson explained. “This process is under way.”
The remarks highlight the European Union’s unified approach to addressing trade challenges, with Germany, as a key member, playing a critical role in shaping any retaliatory measures. The focus remains on evaluating the potential impacts and ensuring that any response aligns with the broader interests of the EU.
As tensions continue to mount between the U.S. and EU over tariffs, it remains to be seen what actions will ultimately be taken.
Source: Reuters
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas